Truist Financial
NMTR

Truist Financial’s 9 Meters Biopharma NMTR Stock Holding History

Truist Financial’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-8,725
Closed -$171K – 2897
2021
Q4 		$171K Hold
8,725
– – ﹤0.01% 2620
2021
Q3 		$227K Hold
8,725
– – ﹤0.01% 2500
2021
Q2 		$192K Sell
8,725
-5
-0.1% -$123 ﹤0.01% 2597
2021
Q1 		$204K Buy
+8,730
New +$268K ﹤0.01% 2485

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Truist Financial's NMTR Position: Q1 2022 in Review

Truist Financial sold out of 9 Meters Biopharma (NMTR) in Q1 2022, closing a stake of 8,725 shares — an estimated $171K sold.

Truist Financial first reported a position in NMTR in Q1 2021 and held it in 4 quarters. The position peaked at $227K in Q3 2021. 101 funds tracked by Wall St. Rank hold NMTR as of Q1 2022.

  • Truist Financial reported no remaining 9 Meters Biopharma position as of Q1 2022 after selling out during the quarter.
  • Truist Financial sold 8,725 9 Meters Biopharma shares in Q1 2022, an estimated $171K.
  • Truist Financial first reported a position in 9 Meters Biopharma in Q1 2021 and held it in 4 quarters.
  • Truist Financial's 9 Meters Biopharma position peaked at $227K in Q3 2021.
  • 101 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q1 2022.

Based on Truist Financial's 13F filing for Q1 2022, filed 22 Apr 2022.